Assessment of Factors That Affected Respiratory Parameters in Mucopolysaccharidoses Patients

NCT04491747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2020-07-29

No results posted yet for this study

Summary

Respiratory system affects in mucopolysaccharidosis (MPS) disease. Respiratory system symptoms are seen in almost every MPS patients and respiratory failure is one of the most common causes of death in this population. The aim of the study was to evaluate respiratory muscle strength and endurance, cough effectiveness and functional capacity in MPS patients and to defined the factors that affected the respiratory problem in this.

Conditions

  • Mucopolysaccharidoses

Interventions

DIAGNOSTIC_TEST

functional capacity

Six minute walk test used assessment of functional capacity.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Deniz Dogru- Ersoz, Professor · Hacettepe University

  • Naciye Vardar- Yagli, PhD · Hacettepe University

  • Dilber Ademhan- Tural, MD · Hacettepe University

  • Nural Kiper, Professor · Hacettepe University

  • Ugur Ozcelik, Professor · Hacettepe University

  • Ebru Yalcin, Professor · Hacettepe University

  • Deniz Inal-Ince, Professor · Hacettepe University

  • Melda Saglam, PhD · Hacettepe University

  • Serap Sivri, Professor · Hacettepe University

  • Aysegul Tokatlı, Professor · Hacettepe University

Eligibility

Min Age
7 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-02-01
Completion
2020-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04491747 on ClinicalTrials.gov